Recalls a homeopathy opportunity

The spate of well-known brand-name recalls of late has created an opportunity of sorts for suppliers of homeopathic remedies, which arguably have a higher safety profile as compared with allopathic medicines.

The most recent recall in the analgesic aisle has come just as PuraMed BioScience is expanding distribution of its LipiGesic-M product for migraines fueled by doctor education. “We found that our early adopters are actually going to be [patients] that are dissatisfied Rx users,” said Russ Mitchell, PuraMed CEO.

Pain relief is one of the largest homeopathic categories sold in mass, according to SPINSscan Conventional data.